FDA Announces Joint Meeting of Endocrinologic and Metabolic Drugs Advisory Committee and Advisory Committee for Pharmaceutical Science

Summary

The US Food and Drug Administration (FDA) has scheduled a joint meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Advisory Committee for Pharmaceutical Science to discuss various pharmaceutical-related topics